DanCann Pharma A/S's latest marketcap:
As of 07/26/2025, DanCann Pharma A/S's market capitalization has reached $648,000.21. According to our data, DanCann Pharma A/S is the 48485th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 648,000.21 |
| Revenue (ttm) | 1.06 M |
| Net Income (ttm) | -1,210,365.34 |
| Shares Out | 3.99 M |
| EPS (ttm) | -0.24 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/25/2025 |
DanCann Pharma A/S's yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/26/2025 | kr6.16 M | $648,000.21 | -46.42% | 48485 |
| 12/30/2024 | kr12.27 M | $1.1 M | 93.08% | 44176 |
| 12/29/2023 | kr6.35 M | $626,578.07 | -88.55% | 43127 |
| 12/30/2022 | kr55.5 M | $5.29 M | -77.01% | 38126 |
| 12/30/2021 | kr241.4 M | $26.55 M | 167.27% | 31286 |
| 12/30/2020 | kr90.32 M | $10.93 M | 31836 |
Company Profile
About DanCann Pharma A/S
DanCann Pharma A/S is a biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of therapeutic cannabinoids for various disease areas.
Core Focus
The company sources, develops, and distributes both prescription and over-the-counter cannabinoid-based pharmaceuticals, with a primary emphasis on pain management solutions.
Development Pipeline
- EXT02 CannGros
- EXT03 CannGros
- EXT04 CannGros
- FLS04 CannGros
- FLS05 CannGros
Product Distribution
DanCann Pharma A/S is also engaged in the import and distribution of the following products:
- Bedrocan CannGros
- Bedica CannGros
- Bediol CannGros
Company Background
Founded in 2018, DanCann Pharma A/S is headquartered in Ansager, Denmark.
Frequently Asked Questions
-
What is DanCann Pharma A/S's (NGM-DANCAN) current market cap?As of 07/26/2025, DanCann Pharma A/S (including the parent company, if applicable) has an estimated market capitalization of $648,000.21 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does DanCann Pharma A/S (NGM-DANCAN) rank globally by market cap?DanCann Pharma A/S global market capitalization ranking is approximately 48485 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.